Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
Affinity DataEC50: >5.00E+3nMAssay Description:Agonist activity at alphaLbeta2 in human Jurkat E6.1 cells assessed as increase in cell adhesion to ICAM1 pre-incubated for 30 mins before ICAM1 and ...More data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: 1.05E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: 1.36E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: 1.80E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: 1.86E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: 2.23E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: 2.32E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: 3.56E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: 4.04E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: 4.09E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: >5.00E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: >5.00E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair
TargetIntegrin alpha-M/beta-2(Homo sapiens (Human))
Department of Medicine and University of Miami
Curated by ChEMBL
Department of Medicine and University of Miami
Curated by ChEMBL
Affinity DataEC50: >5.00E+4nMAssay Description:Agonist activity at CD11b/CD18 expressed in K562 cells assessed as increase in cell adhesion to fibrinogenMore data for this Ligand-Target Pair